Koninklijke Philips (NYSE:PHG) to Issue $0.92 Annual Dividend

Koninklijke Philips (NYSE:PHG) announced an annual dividend on Wednesday, May 8th, Wall Street Journal reports. Investors of record on Friday, May 10th will be given a dividend of 0.9154 per share by the technology company on Thursday, May 9th. This represents a dividend yield of 3.5%. The ex-dividend date of this dividend is Thursday, May 9th.

Koninklijke Philips Price Performance

Shares of NYSE PHG traded down $0.51 during midday trading on Wednesday, reaching $26.00. 1,016,553 shares of the company traded hands, compared to its average volume of 1,190,669. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.78 and a current ratio of 1.20. The firm has a market cap of $24.14 billion, a PE ratio of -27.61, a PEG ratio of 1.39 and a beta of 0.75. Koninklijke Philips has a 12 month low of $17.75 and a 12 month high of $29.44. The stock’s 50-day simple moving average is $21.35 and its 200-day simple moving average is $21.33.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. UBS Group upgraded shares of Koninklijke Philips from a “sell” rating to a “neutral” rating in a report on Tuesday, April 30th. BNP Paribas upgraded shares of Koninklijke Philips from an “underperform” rating to a “neutral” rating in a report on Tuesday. StockNews.com upgraded Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a report on Thursday, February 8th. Finally, JPMorgan Chase & Co. raised shares of Koninklijke Philips from an “underweight” rating to a “neutral” rating in a report on Tuesday, April 30th. Three equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Koninklijke Philips presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.00.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.